EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 147 filers reported holding EXELIXIS INC in Q1 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $149,000 | +16.4% | 10,000 | 0.0% | 0.04% | +22.9% |
| Q3 2016 | $128,000 | +64.1% | 10,000 | 0.0% | 0.04% | +75.0% |
| Q2 2016 | $78,000 | +95.0% | 10,000 | 0.0% | 0.02% | +100.0% |
| Q1 2016 | $40,000 | -32.2% | 10,000 | -4.1% | 0.01% | -28.6% |
| Q4 2015 | $59,000 | -6.3% | 10,430 | -7.1% | 0.01% | -22.2% |
| Q3 2015 | $63,000 | +50.0% | 11,230 | 0.0% | 0.02% | +50.0% |
| Q2 2015 | $42,000 | +44.8% | 11,230 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $29,000 | +81.2% | 11,230 | 0.0% | 0.01% | +100.0% |
| Q4 2014 | $16,000 | -5.9% | 11,230 | 0.0% | 0.00% | -20.0% |
| Q3 2014 | $17,000 | -58.5% | 11,230 | -8.2% | 0.01% | -54.5% |
| Q2 2014 | $41,000 | -4.7% | 12,230 | 0.0% | 0.01% | -8.3% |
| Q1 2014 | $43,000 | -42.7% | 12,230 | 0.0% | 0.01% | -45.5% |
| Q4 2013 | $75,000 | +5.6% | 12,230 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $71,000 | +26.8% | 12,230 | 0.0% | 0.02% | +29.4% |
| Q2 2013 | $56,000 | – | 12,230 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |